There are already two drugs on the market targeting KRAS mutations, for decades considered ... in the phase 1/2 LOXO-RAS-20001 study, which included 17 previously untreated patients.

Cancer patients invariably develop resistance to targeted drugs, so drugmakers develop strategies to combat it before ...

Cancer patients invariably develop resistance to targeted drugs, so drugmakers develop strategies to combat it before ...

Colorectal cancer (CRC), a type of cancer that affects the large intestine and rectum, is one of the leading causes of cancer ...

A cancer-causing protein long thought to be resistant to medication could soon be the target of new drugs, thanks to the work ...

So, I think that’s kind of how you look at it.” Gutekunst said the team doesn’t use RAS “at all.” Rather the team’s analytics staff has its own tool to “measure athletic traits and ...

Credit: Canadian Light Source The researchers found that when the Ras protein is in its mutated, cancer-causing state, "molecules snuggle inside the pocket. Using crystallography, we were able to ...

Somatic mutations, acquired before or after the initiation of chemotherapy, can lead to clinically relevant genetic variations not found in the germline. This has been demonstrated by the ...

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., April 24, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM; HKEX:​13) today announces that new and updated data from ...

Ras Hankorab, a jewel of Wadi el-Gemal National Park known for its untouched marine ecosystem, is currently closed off, its future hanging in the balance. Located 90 minutes from Marsa Alam ...